4.1 Therapeutic indications
Treatment of frequency, urgency or urge incontinence as may occur in bladder overactivity whether due to neurogenic bladder disorders (detrusor hyperreflexia) or idiopathic detrusor overactivity.
Oxybutynin hydrochloride is indicated for children over 5 years for: - Urinary incontinence, urgency and frequency in overactive bladder conditions caused by idiopathic overactive bladder or neurogenic bladder dysfunction (detrusor over activity).
- Nocturnal enuresis associated with detrusor over activity, in conjuction with non-drug therapy , when other treatment not been successful.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).